(204 days)
Not Found
No
The summary describes a dental implant system and does not mention any AI or ML components or functionalities.
No
The device is described as an implant system for supporting dental prostheses to restore chewing function, not for treating or curing a disease or condition.
No
The device is described as an implant system for dental prostheses, focused on providing support and restoring chewing function, not on diagnosing medical conditions.
No
The device description explicitly states it is an "Implant System" intended to be "implanted" in the jaw, indicating a physical, hardware-based device.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a device that is implanted in the body (jaw arches) to provide structural support for dental prostheses. This is a surgical/implantable device, not a device used to examine specimens from the body to provide diagnostic information.
- Device Description: The description reinforces the nature of the device as an implant for supporting dental prostheses.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples, detecting substances, or providing diagnostic information about a patient's health condition.
IVD devices are used outside the body to examine specimens (like blood, urine, tissue) to diagnose diseases or other conditions. This device is implanted inside the body for a structural and functional purpose.
N/A
Intended Use / Indications for Use
The NSI Implant System is intended to be implanted in the upper or lower jaw arches to provide support for fixed or removable dental prostheses in a single tooth, partially edentulous prostheses, or full arch prostheses. It further adds the option for immediate loading on single and splinted multiple unit restorations when good primary stability is achieved and with appropriate occlusal loading, to restore chewing function.
Product codes (comma separated list FDA assigned to the subject device)
DZE, NHA
Device Description
The NSI Implant System is intended to be implanted in the upper or lower jaw arches to provide support for fixed or removable dental prostheses in a single tooth, partially edentulous prostheses, or full arch prostheses. It further adds the option for immediate loading on single and splinted multiple unit restorations when good primary stability is achieved and with appropriate occlusal loading, to restore chewing function.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
upper or lower jaw arches
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Clinical studies were not conducted, or deemed necessary, for the purpose of this 510(k) submission.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K003620, K020617, K033171, K052490, K053478, K053353
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.
0
510(K) PREMARKET NOTIFICATION
Name/Address of Submitter: Southern Implants, Inc. 10355 B Democracy Lane Fairfax, VA 22030
Establishment Registration Number: 3003845138
V 1 6 2007
Contact Person: Greta M. Hols Phone: (703) 278-3953 Fax: (703) 278-3954
Date Summary Prepared: April 6, 2007
Device Classification Name: Endosseous Implant and Accessories
Device Classification Regulation Number: 21 CFR 872.3640 and 21 CFR 872.3630
Device Regulatory Status: Class II Special Controls
Trade Name: Endosseous Dental Implant
Purpose: The purpose of this 510(k) is to include additional implants and accessories in the NSI Endosseous Implant System that did not fall within the size range and design shapes identified in prior 510(k) submissions.
Performance Standards: FDA has not established a performance standard applicable to endosseous implants and their accessories. The materials in the NSI Implant System meet applicable voluntary standards. Southern Implant's screw-type implants and abutments are manufactured from ASTM F67-95 Grade III or Grade IV Titanium.
K003620 NSI Hexed and Non-Hexed Implant System Predicate Devices: K020617 NSI Hexed and Non-Hexed Implant System K033171 NSI Hexed and Non-Hexed Implant System K052490 NSI Hexed and Non-Hexed Implant System K053478 NSI Hexed and Non-Hexed Implant System K053353 MegaGen Co. Rescue Implant System
Device Description and Intended Use: The NSI Implant System is intended to be implanted in the upper or lower jaw arches to provide support for fixed or removable dental prostheses in a single tooth, partially edentulous prostheses, or full arch prostheses. It further adds the option for immediate loading on single and splinted multiple unit restorations when good primary stability is achieved and with appropriate occlusal loading, to restore chewing function.
Sterilization Methods Used: Sterilization of these implants will be achieved using Co60 irradiation, with a minimum dose of 25.0 kGy (2.5 m rads), creating a Sterility Assurance Level of 10 . Validation of sterilization will be done as specified by the Association for the Advancement of Medical Instrumentation (AAMI). Standards utilized include:
| ISO 11137 | Sterilization of Health Care Products – Requirements for validation and routine control –
Radiation sterilization |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| ISO 11737-2 | Sterilization of Medical Devices – Microbial Methods – Part 2: Tests of sterility
performed in the validation of a sterilization process |
| ISO 13409 | Sterilization of Health Care Products – Radiation Sterilization – substantiation of 25kGy as
a sterilization dose for small or infrequent production batches. |
1
Packaging Method: Please note that our implants are packaged the same as our existing line of dental i ackaging Method: "Ticase note non-hexed Implant Systems noted above as predicate devices. Implants are placed into plastic tubing (PT6.1) and capped on both ends. The plastic tube is then heals and in a blister pack consisting of a transparent film (P.E.T.) and a porous sheet material backing (Tyvek1073B). m a blister pack is considered the primary pack (that which provides the microbial barrier) for the implants. The Tyvek is coated with an adhesive. A sterilization indicator sticker is placed on the blister packaging. The blisher with its contents are then enclosed in a clear plastic box and sent for sterilization.
Packaging Validation:
| All Southern Implants packaging is validated following these standards: | |
|---|---|
| ASTM D 4169-04 | Standard Practice for Performance Testing of Shipping Containers and Systems |
| ASTM F 88-00 | Standard Test Method for Seal strength of Flexible Barrier Materials |
| ASTM F 1929-98 | Standard Test Method for Detecting Seal Leaks in Porous Medical Packaging by |
| Dye Penetration | |
| ASTM F 1980 - 02 | Standard Guide for Accelerated Aging of Sterile Medical Device Packages |
| EN 552 | Sterilization of medical devise - Validation and routine control of sterilization by |
| irradiation | |
| EN556 | Sterilization of medical devices - Requirements for medical devices to be labeled |
| "Sterile" | |
| EN 868-1:1997 | Packaging materials and systems for medical devices with are to be sterilized: |
| Part 1 General requirements and test methods | |
| EN 868-5:1999 | Packaging materials and systems for medical devices which are to be sterilized - |
| Part 5: Heat and self-sealable pouches and reels of paper and plastic film | |
| construction - Requirements and test methods | |
| EN 868-9: 2000 | Packaging materials and systems for medical devices which are to be sterilized - |
| Part 9: Uncoated non-woven materials of polyolefines suitable for use as | |
| packaging of medical devices which are to be terminally sterilized - | |
| Requirements and test methods. | |
| EN 868-10:2000 | Packaging materials and systems for medical devices which are to be sterilized - |
| Part 10: Adhesive coated nonwoven material of polyolefines for use in the | |
| manufacture of heat sealable pouches, reels and lids - Requirement s and test | |
| methods | |
| ISO 11607 | Packaging for terminally sterilized medical devices |
Technological Characteristics: The physical properties and designs of the additional implants and accessories in the NSI Endosseous Dental Implant System were compared with legally marketed predicate devices. The technological characteristics were comparable.
Surface Modifications: Please note that this is the same surface medification method currently used with our existing line of dental implants that are cleared NSI hexed and non-hexed Implant Systems noted above as predicate devices. The surface of our implant is blasted using 100 micron alumina (AL203) particles. Alumina is a highly biocompatible material and hence if any particles remain embedded in the surface, they will not pose a complication. The other measure taken to reduce the potential of embeddiment is to blast with relatively low pressure. If the indentations caused are significantly smaller than the size of the blast media, then particles tend to not adhere to the surface. (Our S = 1.43 microns is a fraction of the particle size of 110 microns).Each and every implant is visually inspected under a microscope after surface enhancement as a matter of manufacturing protocol. In addition to visual inspection, a sample implant is sent for SEM testing four times a year for evaluation of the surface as well.
Brief Discussion of Clinical Studies: Clinical studies were not conducted, or deemed necessary, for the purpose of this 510(k) submission.
Conclusions Drawn: The NSI Endosseous Dental Implant System has the same intended use as, and technological characteristics similar to, the legally marketed predicate devices. Any differences in the technological characteristics did not raise new issues of safety or effectiveness.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH AND HUMAN SERVICES, USA" around the perimeter. Inside the circle is a stylized image of a human figure with outstretched arms, representing health and well-being.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV 1 6 2007
Ms. Greta M. Hols Director of Operations Southern Implants, Incorporated 11250 Waples Mill Road, Suite 320 Fairfax, Virginia 22030
Rc: K071161
Trade/Device Name: Endosseous Dental Implant System Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: II Product Code: DZE, NHA Dated: September 14, 2007 Received: September 18, 2007
Dear Ms. Hols:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Ms. Hols
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Nil RP Ogle
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
4
ink) Number: K071161
vice Name: Endosseous Dental Implant System
on for Use: The NSI MAX Implant System is intended for implantation in the law or mandibular molar region where bone exists and the surgeon has determined any of mandioutar moral regioneter implant would increase the probability of placement of a narrotability, or increased surgical procedures leading to cations. This MAX implant provides support for fixed or removable dental eses in a single tooth, partially edentulous prostheses, or full arch prostheses. It socs in a bing on for immediate loading on single and splinted multiple unit tradions when good primary stability is achieved and with appropriate occlusal i ig, to restore chewing function.
CONCURRENCE OF CDRH OFFICE OF DEVICE EVALUATION
Prescription Use X OR Over-the-counter Use __
(Per 21 CFR801.109)
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: